Jason H. Mendler, M.D., Ph.D.

Jason H. Mendler, M.D., Ph.D.

Contact Information

Box 704

Administrative: (585) 275-4099
Fax: (585) 273-1051


Journal Articles

Showing all 9 journal articles available.

2013 Aug
Mendler JH, Maharry K, Becker H, Eisfeld AK, Senter L, Mrózek K, Kohlschmidt J, Metzeler KH, Schwind S, Whitman SP, Khalife J, Caligiuri MA, Klisovic RB, Moore JO, Carter TH, Marcucci G, Bloomfield CD. "In rare acute myeloid leukemia patients harboring both RUNX1 and NPM1 mutations, RUNX1 mutations are unusual in structure and present in the germline." Haematologica.. 2013 Aug; 98(8):e92-4. Epub 2013 Jun 10.
2013 May
Marcucci, G; Maharry, KS; Metzeler, KH; Volinia, S; Wu, YZ; Mrózek, K; Nicolet, D; Kohlschmidt, J; Whitman, SP; Mendler, JH; Schwind, S; Becker, H; Eisfeld, AK; Carroll, AJ; Powell, BL; Kolitz, JE; Garzon, R; Caligiuri, MA; Stone, RM; Bloomfield CD. "Clinical Role of microRNAs in Cytogenetically Normal Acute Myeloid Leukemia: miR-155 Upregulation Independently Identifies High-Risk Patients". J Clin Oncol.. 2013; . Link
2012 Jul 12
Eisfeld AK, Marcucci G, Maharry K, Schwind S, Radmacher MD, Nicolet D, Becker H, Mrózek K, Whitman SP, Metzeler KH, Mendler JH, Wu YZ, Liyanarachchi S, Patel R, Baer MR, Powell BL, Carter TH, Moore JO, Kolitz JE, Wetzler M, Caligiuri MA, Larson RA, Tanner SM, de la Chapelle A, Bloomfield CD. "miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia." Blood.. 2012 Jul 12; 120(2):249-58. Epub 2012 Apr 23.
2012 Jul
Whitman SP, Caligiuri MA, Maharry K, Radmacher MD, Kohlschmidt J, Becker H, Mrózek K, Wu YZ, Schwind S, Metzeler KH, Mendler JH, Wen J, Baer MR, Powell BL, Carter TH, Kolitz JE, Wetzler M, Carroll AJ, Larson RA, Marcucci G, Bloomfield CD. "The MLL partial tandem duplication in adults aged 60 years and older with de novo cytogenetically normal acute myeloid leukemia." Leukemia.. 2012 Jul; 26(7):1713-7. Epub 2012 Feb 07.
Mendler, JH; Maharry, K; Radmacher, MD, Mrozek, K; Becker, H; Metzeler, KH; Schwind, S; Whitman, SP;Khalife, J; Kohlschmidt, J; Nicolet, D; Powell, BL; Carter, TH; Wetzler, M; Moore, JO; Kolitz, JE; Baer, MR; Carroll, AJ; Larson, RA; Caligiuri, MA; Marcucci, G; Bloomfield, CD. "RUNX 1 Mutations Are Associated With Poor Outcome in Younger and Older Patients With Cytogenetically Normal Acute Myeloid Leukemia and With Distinct Gene and MicroRNA Expression Signatures." J Clin Oncol. 2012; . Link
2009 Apr
Mendler JH, Friedberg JW. "Salvage therapy in Hodgkin's lymphoma." The oncologist.. 2009 Apr; 14(4):425-32. Epub 2009 Apr 02.
2008 Oct
Mendler JH, Kelly J, Voci S, Marquis D, Rich L, Rossi RM, Bernstein SH, Jordan CT, Liesveld J, Fisher RI, Friedberg JW. "Bortezomib and gemcitabine in relapsed or refractory Hodgkin's lymphoma." Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2008 Oct; 19(10):1759-64. Epub 2008 May 25.
2005 Nov
Mendler J. "A medical experience that taught me about humanism in medicine." Academic medicine : journal of the Association of American Medical Colleges.. 2005 Nov; 80(11):1066.
1998 Jan
Lissy NA, Van Dyk LF, Becker-Hapak M, Vocero-Akbani A, Mendler JH, Dowdy SF. "TCR antigen-induced cell death occurs from a late G1 phase cell cycle check point." Immunity. 1998 Jan; 8(1):57-65.